首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis of derivatives of (1S,2R)-1-phenyl-2-((S)-1-aminopropyl)-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity.
【24h】

Synthesis of derivatives of (1S,2R)-1-phenyl-2-((S)-1-aminopropyl)-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity.

机译:合成(1S,2R)-1-苯基-2-((S)-1-氨基丙基)-N,N-二乙基环丙烷甲酰胺(PPDC)的衍生物,作为新的NMDA受体拮抗剂改性:芳族基团对于这项活动至关重要。

获取原文
获取原文并翻译 | 示例
           

摘要

(1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC, 4a), which is a conformationally restricted analogue of antidepressant milnacipran [(+/-)-1], is a new class of potent noncompetitive NMDA receptor antagonists. A series of PPDC analogues modified at the 1-phenyl moiety, that is, the analogue 6 lacking 1-phenyl group, the 1-(fluorophenyl) analogues 4b,c,d, the 1-(methylphenyl) analogues 4e-g and the 1-(naphthyl) analogues 4h,i were synthesized. Analogue 6, lacking the 1-phenyl group, was completely inactive showing that the aromatic moiety is essential for the NMDA receptor binding. Among the analogues synthesized, the 1-o-fluorophenyl and 1-m-fluorophenyl analogues 4b and 4c showed potent affinities for the NMDA receptor [IC(50)=0.16+/-0.001 &mgr;M (4b), 0.15+/-0.02 &mgr;M (4c)], which were improved to some extent compared to those of the parent compound PPDC (IC(50)=0.20+/-0.02 &mgr;M). On the other hand, compounds 4b and 4c showed none of the 5-HT-uptake inhibitory effect, while PPDC turned out to be a weak 5-HT-uptake inhibitor.
机译:(1S,2R)-1-苯基-2-[((S)-1-氨基丙基] -N,N-二乙基环丙烷甲酰胺(PPDC,4a),这是抗抑郁剂米那普仑[(+/-)-1是一种新的有效的非竞争性NMDA受体拮抗剂。在1-苯基部分修饰的一系列PPDC类似物,即缺少1-苯基的类似物6、1-(氟苯基)类似物4b,c,d,1-(甲基苯基)类似物4e-g和合成了1-(萘基)类似物4h,i。缺少1-苯基的类似物6是完全无活性的,表明芳族部分对于NMDA受体结合是必不可少的。在合成的类似物中,1-o-氟苯基和1-m-氟苯基类似物4b和4c显示出对NMDA受体的强亲和力[IC(50)= 0.16 +/- 0.001&mgr; M(4b),0.15 +/- 0.02μM(4c)],与母体化合物PPDC相比有所改善(IC(50)= 0.20 +/- 0.02μM)。另一方面,化合物4b和4c没有表现出5-HT摄取抑制作用,而PPDC证明是弱的5-HT摄取抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号